- Intas Pharmaceuticals Ltd. – Offers wide range of formulations from . . .
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR
- Intas Pharmaceuticals - Wikipedia
London -headquartered Accord Healthcare is a fully owned subsidiary of Intas Pharmaceuticals, which deals with large-scale generic pharmaceuticals across Europe and North America markets It also manages an American R D unit which is located at Research Triangle Park, Durham
- Intas Pharmaceuticals - LinkedIn
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world It has been growing at 19% CAGR and crossed the $2 5
- Home page - Intas
Powerful and robust imaging systems for chemiluminescence, fluorescence, bioluminescence, phosphor and UV VIS detection Devices individually tailored to your needs Made in Germany Real-time service Durable robust systems Can be upgraded and converted thanks to modular design
- Accord Healthcare - Advancement. Agility. Accessibility.
Accord Healthcare, Inc , the US subsidiary of Intas Pharmaceuticals, is a leading generic pharmaceutical company headquartered in Durham, North Carolina Through its subsidiaries, Intas markets its products in 80 countries
- Intas Pharmaceuticals Ltd - Company Profile and News
Company profile page for Intas Pharmaceuticals Ltd including stock price, company news, executives, board members, and contact information
- About Us – Intas Pharmaceuticals Ltd.
Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world
- About Intas Pharmaceuticals Ltd. - CPHI Online
Intas Pharmaceuticals, Ltd is a global leader in developing, manufacturing, and marketing generics, biosimilars, and added-value medicines
|